- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 02.04. | Why Biogen Is Paying $5.6B to Buy Apellis Pharma | ||
| 02.04. | AI-Powered Cohorting Is Quietly Reshaping How Real-World Evidence Gets Built | ||
| 02.04. | To Bend the Curve on Heart Disease, Prevention Must Move Upstream | ||
| 02.04. | AI Drug Discovery Is Reshaping Longevity Medicine. Is Your Practice Ready? | ||
| 02.04. | Rural America Doesn't Need Another Framework … It Needs Care by September 2026 | ||
| 02.04. | MedCity FemFwd: ACOG's New Guidelines Around Endometriosis | ||
| 02.04. | WHOOP Secures $575M, Reaches $10B Valuation | ||
| 01.04. | Eli Lilly Gets Speedy FDA Nod for Oral GLP-1 Drug, a Competitor to New Novo Nordisk Pill | ||
| 01.04. | From Cavities to Chronic Disease: Why Medicine and Dentistry Can't Operate Separately | ||
| 01.04. | Fixing Healthcare Means Trusting Doctors and Patients - Not Payers | ||
| 01.04. | The Digital Imperative: Why the Future of Surgery Will Be Built on Integrated Intelligence, Not More Devices | ||
| 01.04. | Healthcare Moves: A Monthly Summary of Hires, Exits and Layoffs | ||
| 01.04. | Jimini Health Raises $17M to Scale Clinician-Supervised AI for Behavioral Health | ||
| 31.03. | Eli Lilly's Neuro Prospects Expand to Sleep Science With $6.3B Centessa Acquisition | ||
| 31.03. | Healthcare Staff can Maximize the Value of AI with High Performing Endpoints | ||
| 31.03. | Concussion Protocols: What Providers Should Know to Diagnose, Treat, and Rehabilitate | ||
| 31.03. | Health Care Technology And Tactics For Addressing Gaps In Patient Communication | ||
| 31.03. | How Mass General Brigham Decides Which AI Tools Are Worth Scaling | ||
| 31.03. | State Mitigation Strategies Could Blunt Medicaid Coverage Losses | ||
| 30.03. | Kailera Plans IPO for Obesity Drug That Could Top Lilly's Zepbound | ||
| 30.03. | MedCity Pivot Podcast: How Fujifilm Tackled An Existential Crisis | ||
| 30.03. | Top-Paying Healthcare Settings for Travel Nurses and How to Land Them | ||
| 30.03. | AI Is Fueling a New Arms Race in Healthcare: Here's How We Stop It | ||
| 30.03. | Red Light Therapy's Regulatory Implications | ||
| 30.03. | Why CREST-2 Trial Results Should Inform, Not Replace, Clinical Judgment |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.